METHOD OF TARGETING A2B ADENOSINE RECEPTOR ANTAGONIST THERAPY

Provided herein are methods for determining if a subject will benefit from A2B receptor antagonist therapy.

Saved in:
Bibliographic Details
Main Author LINDEN JOEL M
Format Patent
LanguageEnglish
Published 15.03.2007
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided herein are methods for determining if a subject will benefit from A2B receptor antagonist therapy.
Bibliography:Application Number: US20060467464